Malignant peritoneal mesothelioma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is GLUT1 expression a major prognostic factor? A preliminary study.

Hommell-Fontaine, J; Isaac, S; Passot, G; Decullier, E; Traverse-Glehen, A; Cotte, E; You, B; Mohamed, F; Gilly, F N; Glehen, O; Berger, F

Hommell-Fontaine, J; Isaac, S; Passot, G; Decullier, E; Traverse-Glehen, A; Cotte, E; You, B; Mohamed, F; Gilly, F N; Glehen, O; Berger, F.

Affiliation

Hommell-Fontaine J; Service de Chirurgie Générale, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.

Ann Surg Oncol ; 20(12): 3892-8, 2013 Nov.

Article in En | MEDLINE | ID: mdl-23800898

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Biomarkers, Tumor/metabolism; Chemotherapy, Cancer, Regional Perfusion; Glucose Transporter Type 1/metabolism; Hyperthermia, Induced; Lung Neoplasms/therapy; Mesothelioma/therapy; Peritoneal Neoplasms/therapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lung Neoplasms/metabolism; Lung Neoplasms/mortality; Male; Mesothelioma/metabolism; Mesothelioma/mortality; Mesothelioma, Malignant; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Peritoneal Neoplasms/metabolism; Peritoneal Neoplasms/mortality; Prognosis; Retrospective Studies; Survival Rate; Tissue Array Analysis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Peritoneal Neoplasms / Chemotherapy, Cancer, Regional Perfusion / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Glucose Transporter Type 1 / Hyperthermia, Induced / Lung Neoplasms / Mesothelioma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Ann Surg Oncol Year: 2013 Type: Article Affiliation country: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google